With one positive and one neutral trial, the jury is still out on whether intra-arterial hypothermia boosts functional outcomes.
Researchers have found in a new study that adjunctive intra-arterial alteplase administered after successful thrombectomy may ...
Now that mechanical thrombectomy has proven to be beneficial in patients with acute ischemic stroke caused by a large vessel occlusion, the question of whether thrombolysis is necessary beforehand has ...
Opinion
Is ATLAS lifting the burden of stroke in people with large-vessel occlusion and low ASPECTS scores?
In Greek mythology, Atlas is the powerful Titan condemned by Zeus to eternally bear the celestial spheres—a profound symbol of endurance and strength. These very virtues are necessitated in patients ...
Two studies have shown no added benefit of intravenous thrombolysis in patients with acute stroke who are treated with mechanical thrombectomy. We review the importance and interpretation of these ...
While the routine use of endovascular thrombectomy has revolutionized the treatment of large vessel occlusion ischemic stroke in recent years, a new a study is addressing whether individual approaches ...
(UPDATED) Mechanical thrombectomy, already shown to improve functional outcomes in appropriately selected patients with acute ischemic stroke who present up to 24 hours after symptom onset, is also ...
Each moment we are given holds possibility. Yet, every 40 seconds a person suffers from a stroke, which can take away that promise of possibility. Millions of Americans and their families are affected ...
Thrombectomy removes blood clot from a blocked blood vessel in the brain and must be performed within 24 hours - but can only ...
PHOENIX -- Endovascular thrombectomy for large-core acute ischemic stroke improved long-term outcomes, the SELECT2 trial affirmed. The intervention shifted the 1-year modified Rankin Scale (mRS) score ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to a Bay Area commercial stage medical technology company for its novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results